TRIALPREDICT
LIVE

Serial Number

79104405

Owner

Informa UK Limited

Attorney

Kathryn Starshak

Filing Date

Mar 31, 2011

Add to watchlist:

No watchlists yet
View on USPTO

TRIALPREDICT Trademark

Serial Number: 79104405 • Registration: 4434289

TRIALPREDICT is a trademark filed by Informa UK Limited on March 31, 2011. The trademark is classified under Class 9 (Computers & Electronics), Class 41 (Education & Entertainment), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

Informa UK Limited (69 trademarks)

5 Howick Place
London SW1P1WG , GB

Entity Type: 11

Trademark Details

Filing Date

March 31, 2011

Registration Date

November 19, 2013

Published for Opposition

September 3, 2013

Cancellation Date

April 1, 2021

Goods & Services

Educational services, namely, providing educational seminars, conferences, classes and workshops in the fields of medical research, clinical trials, pharmaceutical research and development, pharmaceutical drug development services, and healthcare; providing training in the field of medical research, clinical trials, pharmaceutical research and development, pharmaceutical drug development services, and healthcare; arranging and conducting of recreation, entertainment, cultural, training and educational conferences, courses, seminars and exhibitions in the fields of medical research, clinical trials, pharmaceutical research and development, pharmaceutical drug development services, and healthcare; Publishing and issuing of scientific papers in the fields of medical research, clinical trials, pharmaceutical research and development, pharmaceutical drug development services, and healthcare; electronic publishing services, namely, publication of text and graphic works of others online featuring information on medical research, clinical trials, pharmaceutical research and development, pharmaceutical drug development services, and healthcare; Non-downloadable electronic publications in the nature of journals, newsletters, reports, and directories in the fields of medical research, clinical trials, pharmaceutical research and development, pharmaceutical drug development services, and healthcare via the Internet; information, consultancy and advisory services relating to all the aforesaid services including such services provided on-line or via the Internet

Apparatus for recording, transmission or reproduction of sound or images; blank magnetic data carriers and recording discs; prerecorded magnetic data carriers featuring information and data in the fields of medical research, clinical trials, pharmaceutical research and development, pharmaceutical drug development services, and healthcare; blank recording optical discs; pre-recorded CDs, video tapes, laser disks and DVDs featuring information in the fields of medical research, clinical trials, pharmaceutical research and development, pharmaceutical drug development services, and healthcare; computer software for use in database management in the fields of medical research, clinical trials, pharmaceutical research and development, pharmaceutical drug development services, and healthcare; downloadable computer software for use in database management in the fields of medical research, clinical trials, pharmaceutical research and development, pharmaceutical drug development services, and healthcare; computer software for use in database management in the fields of medical research, clinical trials, pharmaceutical research and development, pharmaceutical drug development services, and healthcare and manuals in electronic format sold as a unit; computer software for the provision of information relating to medical research, clinical trials, pharmaceutical research and development, pharmaceutical drug development services, and healthcare; computer software for the analysis of information and data relating to medical research, clinical trials, pharmaceutical research and development, pharmaceutical drug development services, and healthcare; downloadable electronic publications in the nature of newsletters, reports, directories and bulletins in the fields of medical research, clinical trials, pharmaceutical research and development, pharmaceutical drug development services, and healthcare from databases or the internet; computer networking hardware for the processing and storage of data; computer programs for use in database management in the fields of medical research, clinical trials, pharmaceutical research and development, pharmaceutical drug development services, and healthcare; prerecorded magnetic, electronic or optical data carriers featuring information on medical research, clinical trials, pharmaceutical research and development, pharmaceutical drug development services, and healthcare; electronic publications, namely, instruction manuals recorded on computer media relating to use of computers and to data, all recorded magnetically, optically or electronically; magnetic, optical and electronic data recording apparatus for recording of sound, images or data

Medical services; advisory medical services and the provision of medical information; dentistry services; advisory services and the provision of information relating to dentistry; advisory services and the provision of information relating to health; dispensing of pharmaceuticals; veterinary services; medical analysis services; medical testing services for diagnostic or treatment purposes; surgical treatment services; advisory services and the provision of information relating to surgery, including cosmetic surgery; advisory services and the provision of information relating to cosmetic treatment; hygienic and beauty care for human beings or animals; beauty therapy services, namely, medical, hygienic and beauty care services; information, consultancy and advisory services relating to all the aforesaid services including such services provided on-line or via the Internet

Industrial analysis and research services in the field of medical research, clinical trials, pharmaceutical research and development, pharmaceutical drug development services, and healthcare; provision of information including the online provision of such information, relating to medical research, clinical trials, pharmaceutical research and development, pharmaceutical drug development services; design and development of computer hardware and software; design and development of computer software, being software for the provision of information relating to medical research, clinical trials, pharmaceutical research and development, pharmaceutical drug development services, and healthcare; design and development of computer software, being software for the analysis of information and data relating to medical research, clinical trials, pharmaceutical research and development, pharmaceutical drug development services, and healthcare; technological consultancy and advisory services in the field of computer hardware and software; consultancy, design, testing, research and technological advisory services, all relating to computing and computer programming; website design services; computer systems analysis; computer timesharing; research and development of computer hardware and software; technological consulting services relating to computers; rental and leasing of computers; computer programming; computer rental and updating of computer software; computer software design; hosting of websites; hosting of digital content, namely, online journals and blogs; technological consultancy and advisory services in the field of computer networks; computer technology support services, namely, help desk services; technical support services relating to computer hardware, computer software, computer networks and the Internet, namely, troubleshooting in the nature of diagnosing problems relating to computer hardware, computer software, computer networks and the Internet; hosting on-line web facilities for enhancing the performance and function of electronic communications networks; database design and development; consultation in the field of health risk assessment, namely, prediction and assessment of health risks to public and private agencies, facilities, individuals and locations following the administration of chemical, biological, radiological or nuclear materials; compilation of medical research reports; information, consultancy and advisory services relating to all the aforesaid services including such services provided on-line or via the Internet

Filing History

NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Oct 24, 2021 DENC
DEATH OF INTERNATIONAL REGISTRATION
Oct 24, 2021 DETH
CANCELLED SECTION 71
Feb 26, 2021 C71T
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Nov 19, 2018 REM3
CHANGE OF NAME/ADDRESS REC'D FROM IB
Oct 8, 2015 ADCH
FINAL DECISION TRANSACTION PROCESSED BY IB
Mar 6, 2014 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Feb 19, 2014 FICS
FINAL DISPOSITION PROCESSED
Feb 19, 2014 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Feb 19, 2014 FICR
NOTIFICATION PROCESSED BY IB
Nov 23, 2013 GPNX
REGISTERED-PRINCIPAL REGISTER
Nov 19, 2013 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sep 3, 2013 NPUB
PUBLISHED FOR OPPOSITION
Sep 3, 2013 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Aug 28, 2013 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Aug 28, 2013 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Aug 14, 2013 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Jul 30, 2013 PREV
ASSIGNED TO LIE
Jul 26, 2013 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 9, 2013 CNSA
EXAMINER'S AMENDMENT ENTERED
Jul 9, 2013 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jul 9, 2013 GNEN
EXAMINERS AMENDMENT E-MAILED
Jul 9, 2013 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jul 9, 2013 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 18, 2013 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 18, 2013 CRFA
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
May 4, 2013 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Apr 17, 2013 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Apr 17, 2013 OPNR
NEW REPRESENTATIVE AT IB RECEIVED
Apr 5, 2013 NREP
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 3, 2013 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 3, 2013 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Apr 3, 2013 ERFR
NOTIFICATION OF FINAL REFUSAL EMAILED
Oct 4, 2012 GNFN
FINAL REFUSAL E-MAILED
Oct 4, 2012 GNFR
FINAL REFUSAL WRITTEN
Oct 4, 2012 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 13, 2012 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 12, 2012 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 12, 2012 TROA
ATTORNEY REVIEW COMPLETED
Jul 9, 2012 ATRV
LIMITATION OF GOODS/SERVICES FROM IB ENTERED
Jun 18, 2012 LIMS
LIMITATION OF GOODS RECEIVED FROM IB
Jun 6, 2012 LIMG
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
May 25, 2012 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
May 25, 2012 REAP
NON-FINAL ACTION MAILED
Mar 12, 2012 CNRT
NON-FINAL ACTION WRITTEN
Mar 9, 2012 CNRT
LIMITATION OF GOODS/SERVICES FROM IB ENTERED
Feb 17, 2012 LIMS
LIMITATION OF GOODS RECEIVED FROM IB
Feb 3, 2012 LIMG
REFUSAL PROCESSED BY IB
Dec 24, 2011 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Nov 28, 2011 RFCS
REFUSAL PROCESSED BY MPU
Nov 28, 2011 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Nov 26, 2011 RFCR
NON-FINAL ACTION WRITTEN
Nov 25, 2011 CNRT
APPLICATION FILING RECEIPT MAILED
Nov 22, 2011 MAFR
ASSIGNED TO EXAMINER
Nov 18, 2011 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 18, 2011 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Nov 17, 2011 REPR